1 |
DUA H S, SAID D G, MESSMER E M, et al. Neurotrophic keratopathy[J]. Prog Retin Eye Res, 2018, 66: 107-131.
|
2 |
BONINI S, RAMA P, OLZI D, et al. Neurotrophic keratitis[J]. Eye, 2003, 17(8): 989-995.
|
3 |
LAUNAY P S, GODEFROY D, KHABOU H, et al. Combined 3DISCO clearing method, retrograde tracer and ultramicroscopy to map corneal neurons in a whole adult mouse trigeminal ganglion[J]. Exp Eye Res, 2015, 139: 136-143.
|
4 |
LABETOULLE M, BAUDOUIN C, CALONGE M, et al. Role of corneal nerves in ocular surface homeostasis and disease[J]. Acta Ophthalmol, 2019, 97(2): 137-145.
|
5 |
AL-AQABA M A, DHILLON V K, MOHAMMED I, et al. Corneal nerves in health and disease[J]. Prog Retin Eye Res, 2019, 73: 100762.
|
6 |
DHILLON V K, ELALFY M S, AL-AQABA M, et al. Corneal hypoesthesia with normal sub-basal nerve density following surgery for trigeminal neuralgia[J]. Acta Ophthalmol, 2016, 94(1): e6-e10.
|
7 |
SACCHETTI M, LAMBIASE A. Diagnosis and management of neurotrophic keratitis[J]. Clin Ophthalmol, 2014, 8: 571-579.
|
8 |
LOCKWOOD A, HOPE-ROSS M, CHELL P. Neurotrophic keratopathy and diabetes mellitus[J]. Eye (Lond), 2006, 20(7): 837-839.
|
9 |
LUM E, MURPHY P J. Effects of ambient humidity on the cochet-bonnet aesthesiometer[J]. Eye (Lond), 2018, 32(10): 1644-1651.
|
10 |
ZHANG J Y, ZHAO Z L, SHAO C Y, et al. Degeneration of corneal sensation and innervation in patients with facial paralysis: a cross-sectional study using in vivo confocal microscopy[J]. Curr Eye Res, 2019, 44(11): 1209-1215.
|
11 |
KUGADAS A, GADJEVA M. Impact of microbiome on ocular health[J]. Ocul Surf, 2016, 14(3): 342-349.
|
12 |
NIWANO Y, IWASAWA A, AYAKI M. Ocular surface cytotoxicity and safety evaluation of tafluprost, a recently developed anti-glaucoma prostaglandin analog[J]. Ophthalmol Eye Dis, 2014, 6: 5-12.
|
13 |
GEERLING G, TAUBER J, BAUDOUIN C, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction[J]. Invest Ophthalmol Vis Sci, 2011, 52(4): 2050-2064.
|
14 |
HOY S M. Ciclosporin ophthalmic emulsion 0.1%: a review in severe dry eye disease[J]. Drugs, 2017, 77(17): 1909-1916.
|
15 |
MIYAZAKI D, FUKUSHIMA A, OHASHI Y, et al. Steroid-sparing effect of 0.1% tacrolimus eye drop for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseases[J]. Ophthalmology, 2017, 124(3): 287-294.
|
16 |
KOH K, JUN I, KIM T I, et al. Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patients[J]. BMC Ophthalmol, 2021, 21(1): 247.
|
17 |
PELLEGRINI M, SENNI C, BERNABEI F, et al. The role of nutrition and nutritional supplements in ocular surface diseases[J]. Nutrients, 2020, 12(4): 952.
|
18 |
GOMES J A P, AZAR D T, BAUDOUIN C, et al. TFOS DEWS Ⅱ iatrogenic report[J]. Ocul Surf, 2017, 15(3): 511-538.
|
19 |
SHTEIN R M, SHEN J F, KUO A N, et al. Autologous serum-based eye drops for treatment of ocular surface disease: a report by the American academy of ophthalmology[J]. Ophthalmology, 2020, 127(1): 128-133.
|
20 |
MANSOOR H, TAN H C, LIN M T Y, et al. Diabetic corneal neuropathy[J]. J Clin Med, 2020, 9(12): 3956.
|
21 |
HAHN J N, KAUSHIK D K, MISHRA M K, et al. Impact of minocycline on extracellular matrix metalloproteinase inducer, a factor implicated in multiple sclerosis immunopathogenesis[J]. J Immunol, 2016, 197(10): 3850-3860.
|
22 |
SOLEIMANI M, NADERAN M. Management strategies of ocular chemical burns: current perspectives[J]. Clin Ophthalmol, 2020, 14: 2687-2699.
|
23 |
DEEKS E D, LAMB Y N. Cenegermin: a review in neurotrophic keratitis[J]. Drugs, 2020, 80(5): 489-494.
|
24 |
CHAN C C, PROKOPICH C L. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: overview of clinical trial program[J]. J Pharm Pharm Sci, 2019, 22(1): 49-56.
|
25 |
SOSNE G, RIMMER D, KLEINMAN H K, et al. Thymosin β 4: a potential novel therapy for neurotrophic keratopathy, dry eye, and ocular surface diseases[J]. Vitam Horm, 2016, 102: 277-306.
|
26 |
PFLUGFELDER S C, MASSARO-GIORDANO M, PEREZ V L, et al. Topical recombinant human nerve growth factor (cenegermin) for neurotrophic keratopathy: a multicenter randomized vehicle-controlled pivotal trial[J]. Ophthalmology, 2020, 127(1): 14-26.
|
27 |
FERRARI M P, MANTELLI F, SACCHETTI M, et al. Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial[J]. BioDrugs, 2014, 28(3): 275-283.
|
28 |
BONINI S, LAMBIASE A, RAMA P, et al. Phase Ⅰ trial of recombinant human nerve growth factor for neurotrophic keratitis[J]. Ophthalmology, 2018, 125(9): 1468-1471.
|
29 |
BONINI S, LAMBIASE A, RAMA P, et al. Phase Ⅱ randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis[J]. Ophthalmology, 2018, 125(9): 1332-1343.
|
30 |
RIESTRA A C, ALONSO-HERREROS J M, MERAYO-LLOVES J. Platelet rich plasma in ocular surface[J]. Arch Soc Esp Oftalmol, 2016, 91(10): 475-490.
|
31 |
GIANNACCARE G, VERSURA P, BUZZI M, et al. Blood derived eye drops for the treatment of cornea and ocular surface diseases[J]. Transfus Apher Sci, 2017, 56(4): 595-604.
|
32 |
SONI N G, JENG B H. Blood-derived topical therapy for ocular surface diseases[J]. Br J Ophthalmol, 2016, 100(1): 22-27.
|
33 |
ALIO J L, RODRIGUEZ A E, ABDELGHANY A A, et al. Autologous platelet-rich plasma eye drops for the treatment of post-LASIK chronic ocular surface syndrome[J]. J Ophthalmol, 2017, 2017: 2457620.
|
34 |
WU X D, MA Y J, CHEN X, et al. Efficacy of bandage contact lens for the management of dry eye disease after cataract surgery[J]. Int Ophthalmol, 2021, 41(4): 1403-1413.
|
35 |
WABBELS B. Botulinum toxin-new developments in ophthalmology[J]. Klin Monbl Augenheilkd, 2018, 235(6): 721-724.
|
36 |
ERVIN A M, LAW A, PUCKER A D. Punctal occlusion for dry eye syndrome[J]. Cochrane Database Syst Rev, 2017, 6(6): CD006775.
|
37 |
TONG L, ZHOU L, BEUERMAN R, et al. Effects of punctal occlusion on global tear proteins in patients with dry eye[J]. Ocul Surf, 2017, 15(4): 736-741.
|
38 |
KIM B M, OSMANOVIC S S, EDWARD D P. Pyogenic granulomas after silicone punctal plugs: a clinical and histopathologic study[J]. Am J Ophthalmol, 2005, 139(4): 678-684.
|
39 |
CHI J J. Management of the eye in facial paralysis[J]. Facial Plast Surg Clin North Am, 2016, 24(1): 21-28.
|
40 |
KHOKHAR S, NATUNG T, SONY P, et al. Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial[J]. Cornea, 2005, 24(6): 654-660.
|
41 |
MANTELLI F, NARDELLA C, TIBERI E, et al. Congenital corneal anesthesia and neurotrophic keratitis: diagnosis and management[J]. Biomed Res Int, 2015, 2015: 805876.
|
42 |
GUHAN S, PENG S L, JANBATIAN H, et al. Surgical adhesives in ophthalmology: history and current trends[J]. Br J Ophthalmol, 2018, 102(10): 1328-1335.
|
43 |
ZEMBA M, STAMATE AC, TATARU C P, et al. Conjunctival flap surgery in the management of ocular surface disease (Review)[J]. Exp Ther Med, 2020, 20(4): 3412-3416.
|
44 |
DUA H S, OTRI A M, SAID D G, et al. The 'up-down' sign of acute ocular surface drug toxicity[J]. Br J Ophthalmol, 2012, 96(11): 1439-1440.
|
45 |
JONAS J B, RANK R M, BUDDE W M. Tectonic sclerokeratoplasty and tectonic penetrating keratoplasty as treatment for perforated or predescemetal corneal ulcers[J]. Am J Ophthalmol, 2001, 132(1): 14-18.
|
46 |
SAMII M. Modern aspects of peripheral and cranial nerve surgery//KRAYENBÜHL H, BRIHAYE J, LOEW F, et al. Advances and technical standards in neurosurgery[M]. Vienna: Spinger, 1975: 33-85.
|
47 |
SAMII M. Reconstruction of the trigeminal nerve//SAMII M, JANNETTA P J.The cranial nerves[M]. Berlin: Springer, 1981: 352-358.
|
48 |
TERZIS J K, DRYER M M, BODNER B I. Corneal neurotization: a novel solution to neurotrophic keratopathy[J]. Plast Reconstr Surg, 2009, 123(1): 112-120.
|
49 |
ELBAZ U, BAINS R, ZUKER R M, et al. Restoration of corneal sensation with regional nerve transfers and nerve grafts: a new approach to a difficult problem[J]. JAMA Ophthalmol, 2014, 132(11): 1289-1295.
|
50 |
BAINS RD, ELBAZ U, ZUKER R M, et al. Corneal neurotization from the supratrochlear nerve with sural nerve grafts: a minimally invasive approach[J]. Plast Reconstr Surg, 2015, 135(2): 397e-400e.
|
51 |
BIGLIOLI F. Facial reanimations: part Ⅰ: recent paralyses[J]. Br J Oral Maxillofac Surg, 2015, 53(10): 901-906.
|
52 |
JACINTO F, ESPANA E, PADILLA M, et al. Ipsilateral supraorbital nerve transfer in a case of recalcitrant neurotrophic keratopathy with an intact ipsilateral frontal nerve: a novel surgical technique[J]. Am J Ophthalmol Case Rep, 2016, 4: 14-17.
|
53 |
MALHOTRA R, ELALFY M S, KANNAN R B, et al. Update on corneal neurotisation[J]. Br J Ophthalmol, 2019, 103(1): 26-35.
|
54 |
CATAPANO J, FUNG S S M, HALLIDAY W, et al. Treatment of neurotrophic keratopathy with minimally invasive corneal neurotisation: long-term clinical outcomes and evidence of corneal reinnervation[J]. Br J Ophthalmol, 2019, 103(12): 1724-1731.
|